Wnt-Signaling-Mediated Antiosteoporotic Activity of Porcine Placenta Hydrolysates in Ovariectomized Rats
Authors:
Open Access
- 1 January 2012
- journal article
- research article
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2012, 1-9
Abstract
Anti-osteoporotic effects of two types of porcine placenta hydrolysates (PPH) were evaluated in ovariectomized (OVX) rats orally administered PPH without (WPPH) or with (NPPH) ovarian hormones (1 g/kg bw/day). PPH groups were compared with OVX rats with estrogen replacement (0.1 mg/kg bw conjugated estrogen; EST), or dextrose (placebo; OVX-control) All rats received high-fat/calcium-deficient diets for 12 weeks. NPPH contained less estrogen and progesterone, but more essential amino acids, whereas the opposite was true for WPPH. NPPH decreased body weight and peri-uterine fat pads, and maintained uterus weight. NPPH rats had higher femur and lumbar spine bone mass density compared to controls; but less than those of EST rats. Serum phosphorus and urinary calcium and phosphorus levels were reduced in NPPH rats compared to OVX-controls. Serum bone-specific alkaline phosphatase, osteocalcin, and bone turnover marker levels were reduced NPPH rats compared to OVX-controls. WPPH produced results similar to those of NPPH, but less significant. Both NPPH and estrogen upregulated low-density lipoprotein receptor-related protein 5 andβ-catenin in OVX rats, while the expression of dickkopf-related protein 1 was suppressed. In conclusion, NPPH exerted anti-osteoporotic effects by activating osteogenesis and stimulating Wnt signaling, possibly mediated by the various amino acids and not ovarian hormones.Keywords
Funding Information
- Korea Institute of Oriental Medicine (K12080)
This publication has 46 references indexed in Scilit:
- Update on Wnt signaling in bone cell biology and bone diseaseGene, 2012
- Osteoporosis: now and the futureThe Lancet, 2011
- Flemingia macrophylla Extract Ameliorates Experimental Osteoporosis in Ovariectomized RatsEvidence-Based Complementary and Alternative Medicine, 2011
- Wnt signaling as a therapeutic target for bone diseasesExpert Opinion on Therapeutic Targets, 2009
- Regulation of bone mass by Wnt signalingJournal of Clinical Investigation, 2006
- Potential use of biochemical markers of bone turnover for assessing the effect of calcium supplementation and predicting fracture riskClinical Therapeutics, 2005
- Effects of Conjugated Equine Estrogen in Postmenopausal Women With HysterectomyJAMA, 2004
- Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of OsteoporosisEndocrine Reviews, 2000
- Osteoporosis in anorexia nervosa: The influence of peak bone density, bone loss, oral contraceptive use, and exerciseJournal of Bone and Mineral Research, 1992
- CalcitoninNew England Journal of Medicine, 1981